Mr. Prygocki has served as a member of the Verrica Pharmaceuticals Board of Directors since May 2018. He currently serves as Executive Director and Chairman of the Audit Committee of Clarus Pharmaceuticals, Inc. a privately held pharmaceutical company. He has served as the President, CEO and member of the Board of Directors of Illustris Pharmaceuticals, Inc., a privately held biodevelopment company. He previously worked at Medicis Pharmaceutical Corporation, a biopharmaceutical company, for more than 20 years, serving as its President from 2010 to 2012. Prior to that post, Mr. Prygocki held several senior-level positions at Medicis, including COO, Executive Vice President, and CFO and Treasurer. Since 2012, he has also served as a consultant to the pharmaceutical and retail industries through his consulting company. He is certified by the American Institute of Certified Public Accountants, and holds a BS in Accounting from Pace University.


Verrica Receives Permanent J‑Code for YCANTH™